Medical2Market B.V.

Medical2Market B.V. manufactures the HemoClear device, which is designed for blood purification or filtration. Based on the device class and description, it likely addresses medical needs in critical care or dialysis by removing contaminants or toxins from blood. The company focuses on developing technologies that address specific medical challenges in a safe and effective manner.

Medical2Market B.V. is headquartered in the Netherlands. The company’s location in the Netherlands places it within the European Union, which influences its regulatory compliance and device registration processes under EU frameworks.

Medical2Market B.V.’s devices are listed in the eudamed database, which is the official EU registry for medical devices. This registration is required under EU Medical Device Regulations (MDR) to ensure transparency and traceability of devices marketed within the European Union.

Medical2Market B.V.’s devices are classified as Class IIa and Class IIb under EU Medical Device Regulations. This classification indicates that the devices pose moderate (Class IIa) to higher (Class IIb) risks, requiring stricter regulatory oversight, such as conformity assessments and additional documentation to ensure safety and performance before market placement.